Skip to content

CIK 0001642453

DSKE Daseke, Inc.

Insider trading from SEC Form 4. Last filing Mar 27, 2024.

In brief

Daseke, Inc. (DSKE) has 14 SEC Form 4 filings on file from 10 insiders, the latest filed on Mar 27, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company

Signals

Open-market buys and sells at Daseke, Inc., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

Every row filed, 37 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 26, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
GGift
Common Stock
-226,058$0.00$00Mar 27, 2024
Mar 15, 2024Jonathan Shepko
CEO
AGrant or award
Common Stock
+276,968$0.00$0714,165Mar 18, 2024
Mar 15, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
AGrant or award
Common Stock
+31,796$0.00$0233,801Mar 18, 2024
Mar 15, 2024Jonathan Shepko
CEO
FTax withholding
Common Stock
-108,991$8.25$899k605,174Mar 18, 2024
Mar 15, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
FTax withholding
Common Stock
-7,743$8.25$64k226,058Mar 18, 2024
Mar 1, 2024Aaron Coley
EVP and CFO
MOption exercise
Common Stock
+15,236$0.00$0100,342Mar 5, 2024
Mar 1, 2024Aaron Coley
EVP and CFO
FTax withholding
Common Stock
-4,278$8.25$35k96,064Mar 5, 2024
Mar 1, 2024Aaron Coley
EVP and CFO
MOption exercise
Restricted Stock Unitderivative
-15,236$0.00$0152,502Mar 5, 2024
Jan 1, 2024Charles F Serianni
director
MOption exercise
Common Stock
+19,332$0.00$081,326Jan 3, 2024
Dec 31, 2023Jonathan Shepko
CEO
MOption exercise
Common Stock
+61,561$0.00$0443,571Jan 3, 2024
Jan 1, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
MOption exercise
Common Stock
+7,068$0.00$0199,156Jan 3, 2024
Jan 1, 2024Williams Ena Koschel
director
MOption exercise
Common Stock
+19,332$0.00$083,326Jan 3, 2024
Jan 1, 2024Melendy E Lovett
director
MOption exercise
Common Stock
+19,332$0.00$039,585Jan 3, 2024
Jan 1, 2024Grant Edward Garbers
director
MOption exercise
Common Stock
+19,332$0.00$036,491Jan 3, 2024
Jan 1, 2024Catharine D Ellingsen
director
MOption exercise
Common Stock
+19,332$0.00$038,496Jan 3, 2024
Jan 1, 2024Brian Bonner
director
MOption exercise
Common Stock
+19,332$0.00$0514,131Jan 3, 2024
Jan 1, 2024Bruce Blaise
director
MOption exercise
Common Stock
+19,332$0.00$023,897Jan 3, 2024
Jan 1, 2024Grant Edward Garbers
director
MOption exercise
Restricted Stock Unitderivative
-19,332$0.00$00Jan 3, 2024
Jan 1, 2024Melendy E Lovett
director
MOption exercise
Restricted Stock Unitderivative
-19,332$0.00$00Jan 3, 2024
Jan 1, 2024Brian Bonner
director
MOption exercise
Restricted Stock Unitderivative
-19,332$0.00$00Jan 3, 2024
Jan 1, 2024Charles F Serianni
director
MOption exercise
Restricted Stock Unitderivative
-19,332$0.00$00Jan 3, 2024
Jan 1, 2024Williams Ena Koschel
director
MOption exercise
Restricted Stock Unitderivative
-19,332$0.00$00Jan 3, 2024
Jan 1, 2024Bruce Blaise
director
MOption exercise
Restricted Stock Unitderivative
-19,332$0.00$00Jan 3, 2024
Jan 1, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
FTax withholding
Common Stock
-2,096$8.10$17k197,060Jan 3, 2024
Jan 1, 2024Catharine D Ellingsen
director
MOption exercise
Restricted Stock Unitderivative
-19,332$0.00$00Jan 3, 2024
Dec 31, 2023Jonathan Shepko
CEO
FTax withholding
Common Stock
-24,225$8.10$196k419,346Jan 3, 2024
Jan 1, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
MOption exercise
Common Stock
+7,030$0.00$0204,090Jan 3, 2024
Dec 31, 2023Jonathan Shepko
CEO
MOption exercise
Common Stock
+29,433$0.00$0448,779Jan 3, 2024
Jan 1, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
FTax withholding
Common Stock
-2,085$8.10$17k202,005Jan 3, 2024
Dec 31, 2023Jonathan Shepko
CEO
FTax withholding
Common Stock
-11,582$8.10$94k437,197Jan 3, 2024
Jan 1, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
MOption exercise
Restricted Stock Unitderivative
-7,068$0.00$064,063Jan 3, 2024
Dec 31, 2023Jonathan Shepko
CEO
MOption exercise
Restricted Stock Unitderivative
-61,561$0.00$0288,042Jan 3, 2024
Jan 1, 2024Soumit Roy
EVP, CLO, GC and Corp. Sec.
MOption exercise
Restricted Stock Unitderivative
-7,030$0.00$057,033Jan 3, 2024
Dec 31, 2023Jonathan Shepko
CEO
MOption exercise
Restricted Stock Unitderivative
-29,433$0.00$0258,609Jan 3, 2024
Oct 28, 2023Aaron Coley
EVP and CFO
MOption exercise
Common Stock
+112,500$0.00$0112,500Oct 31, 2023
Oct 28, 2023Aaron Coley
EVP and CFO
FTax withholding
Common Stock
-27,394$4.32$118k85,106Oct 31, 2023
Oct 28, 2023Aaron Coley
EVP and CFO
MOption exercise
Restricted Stock Unitderivative
-112,500$0.00$0167,738Oct 31, 2023

Insiders

Everyone who has filed a Form 4 here.

Questions about DSKE

Answered from the filings on this page, as of the latest one.

Are insiders buying DSKE?

No. In the last 90 days no insider at Daseke, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade DSKE on the open market?

No open-market trade has been scored at Daseke, Inc.. The latest Form 4 on file was filed on Mar 27, 2024 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at Daseke, Inc.?

10 people have filed a Form 4 at Daseke, Inc., among them Bruce Blaise (director), Brian Bonner (director), Aaron Coley (EVP and CFO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

DSKE insider trading: Daseke, Inc. | InsiderTell